These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8212839)

  • 21. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico.
    Sack DA; Shimko J; Torres O; Bourgeois AL; Francia DS; Gustafsson B; Kärnell A; Nyquist I; Svennerholm AM
    Vaccine; 2007 May; 25(22):4392-400. PubMed ID: 17448578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrhea.
    Borde A; Ekman A; Larsson A; Carlin N; Holmgren J; Tobias J
    Eur J Pharm Biopharm; 2016 Nov; 108():18-24. PubMed ID: 27485398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination.
    Holmgren J; Svennerholm AM; Gothefors L; Jertborn M; Stoll B
    Infect Immun; 1988 Jan; 56(1):230-3. PubMed ID: 3275584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants.
    Savarino SJ; Hall ER; Bassily S; Wierzba TF; Youssef FG; Peruski LF; Abu-Elyazeed R; Rao M; Francis WM; El Mohamady H; Safwat M; Naficy AB; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD;
    Pediatr Infect Dis J; 2002 Apr; 21(4):322-30. PubMed ID: 12075764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
    Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age.
    Qadri F; Ahmed T; Ahmed F; Bradley Sack R; Sack DA; Svennerholm AM
    Vaccine; 2003 Jun; 21(19-20):2394-403. PubMed ID: 12744870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.
    Wennerås C; Qadri F; Bardhan PK; Sack RB; Svennerholm AM
    Infect Immun; 1999 Dec; 67(12):6234-41. PubMed ID: 10569732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
    Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
    Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
    Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
    Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
    Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
    Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
    Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
    Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
    Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
    Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults.
    Alam MM; Aktar A; Afrin S; Rahman MA; Aktar S; Uddin T; Rahman MA; Al Mahbuba D; Chowdhury F; Khan AI; Bhuiyan TR; Begum YA; Ryan ET; Calderwood SB; Svennerholm AM; Qadri F
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2822. PubMed ID: 24762744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
    Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
    Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.
    Mirhoseini A; Amani J; Nazarian S
    Microb Pathog; 2018 Apr; 117():162-169. PubMed ID: 29474827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area.
    Stoll BJ; Svennerholm AM; Gothefors L; Barua D; Huda S; Holmgren J
    J Infect Dis; 1986 Mar; 153(3):527-34. PubMed ID: 3512729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.